Alcohol Use Disorder

On this page

AUD: Definition & Epidemiology - The Indian Pint‑demic

  • Definition (DSM-5): Problematic alcohol use; ≥2 of 11 criteria in 12 months, causing distress/impairment.
  • Indian Prevalence (NDDUS 2019, 10-75 yrs):
    • Current users: ~14.6% (~160 million).
    • Dependence: ~2.7% (~29 million); M:F ratio ~17:1.
    • Higher in e.g., Arunachal Pradesh, Tripura, Punjab.
  • Key Risk Factors: Genetic predisposition, early initiation, peer pressure, comorbid mental health conditions.

⭐ In India, ~40% of road traffic accidents are attributable to alcohol use (NDDUS 2019).

AUD: Neurobiology & Pathophysiology - Brain Under the Influence

  • Acute Effects: Enhances GABAergic (inhibitory) transmission (sedation, anxiolysis); inhibits NMDA glutamatergic (excitatory) transmission. Releases dopamine in mesolimbic pathway (reward).
  • Chronic Use & Neuroadaptation:
    • ↓ GABA-A receptor function & density.
    • ↑ NMDA receptor density & sensitivity (upregulation).
    • Dysregulation of dopamine, serotonin, and opioid peptide systems.
  • Withdrawal Syndrome: Results from abrupt cessation. Characterized by CNS hyperexcitability (↓GABA, ↑glutamate activity) → tremors, anxiety, seizures, delirium tremens.
  • Kindling: Repeated withdrawal episodes sensitize the brain, lowering seizure threshold.

Neurotransmitter changes in alcohol dependence/withdrawal

⭐ Chronic alcohol exposure leads to a hyperexcitable state upon cessation due to GABA receptor downregulation and NMDA receptor upregulation, underlying withdrawal symptoms like seizures and DTs.

AUD: Clinical Features & Diagnosis - Signs of the Spirits

  • Intoxication: Slurred speech, incoordination, nystagmus, impaired memory.
  • Withdrawal (6-24h onset):
    • Autonomic hyperactivity (↑HR >100, sweating)
    • Tremor, insomnia, N/V, anxiety
    • Hallucinations (visual/tactile)
    • Seizures ("rum fits", 12-48h)
    • Delirium Tremens (DTs, 48-96h): Disorientation, agitation, fever, ↑autonomic signs. Emergency!
  • Diagnosis (DSM-5):2 criteria/12mo (impaired control, social issues, risky use, tolerance/withdrawal).
    • Severity: Mild (2-3), Moderate (4-5), Severe (≥6).
  • Markers: ↑GGT, ↑MCV, AST:ALT >2. CDT for chronic use.

⭐ Wernicke's Encephalopathy triad: Confusion, Ataxia, Ophthalmoplegia (📌 CAO). Often incomplete.

AUD: Complications - The Hangover's Harm

  • Neuro: Wernicke-Korsakoff (Thiamine def.), cerebellar degen., neuropathy, seizures, hepatic encephalopathy.
  • GI: Gastritis, PUD, Mallory-Weiss, varices, pancreatitis, ALD (steatosis, hepatitis, cirrhosis → HCC).
  • CVS: Alcoholic cardiomyopathy, HTN, arrhythmias (holiday heart).
  • Psych: Depression, anxiety, ↑suicide risk, psychosis.
  • Heme: Macrocytosis, thrombocytopenia.
  • Metabolic: Hypoglycemia, alcoholic ketoacidosis.
  • Other: Fetal Alcohol Syndrome (FAS). Alcoholic Cardiomyopathy vs. Normal Heart

⭐ Wernicke's encephalopathy triad: Confusion, Ataxia, Ophthalmoplegia (📌 CAO). Reversible with IV thiamine before glucose administration to prevent precipitation/worsening of Wernicke's.

AUD: Management - Path to Sobriety

  • Withdrawal Management:
    • Benzodiazepines (e.g., Chlordiazepoxide, Lorazepam): Symptom-triggered or fixed-schedule, guided by CIWA-Ar (target < 8-10).
    • Thiamine 100mg IV/IM daily for 3-5 days (prevents Wernicke-Korsakoff).
    • Supportive care: IV fluids, electrolytes.
  • Maintenance (Relapse Prevention):
    • Naltrexone (50mg OD / long-acting IM): Reduces craving & heavy drinking.
    • Acamprosate: Supports abstinence by reducing protracted withdrawal.
    • Disulfiram: Aversive therapy (aldehyde dehydrogenase inhibitor). ⚠️ Monitor LFTs.
    • Psychosocial therapies (AA, CBT, MI) are essential adjuncts.

⭐ Naltrexone can be initiated while still drinking to reduce consumption; Acamprosate/Disulfiram require abstinence.

High‑Yield Points - ⚡ Biggest Takeaways

  • CAGE questionnaire (Cut down, Annoyed, Guilty, Eye-opener) is a key screening tool.
  • Delirium tremens (DT): severe, life-threatening withdrawal, peaks 48-96 hours post-cessation.
  • Wernicke-Korsakoff syndrome: from thiamine (B1) deficiency; Wernicke's (reversible triad), Korsakoff's (irreversible amnesia).
  • Key drugs: Disulfiram (aversive), Naltrexone (↓ cravings), Acamprosate (maintains abstinence).
  • Elevated GGT & MCV are common biochemical markers of chronic alcohol use.
  • Acute alcohol withdrawal: manage with benzodiazepines (e.g., chlordiazepoxide, lorazepam).
  • Fetal Alcohol Syndrome (FAS): distinct facial dysmorphism, growth deficits, CNS issues.

Practice Questions: Alcohol Use Disorder

Test your understanding with these related questions

Which of the following is a validated screening tool for alcohol use disorder?

1 of 5

Flashcards: Alcohol Use Disorder

1/7

_____ hallucinations are common in alcohol withdrawal and stimulant use (e.g. cocaine, amphetamines)

TAP TO REVEAL ANSWER

_____ hallucinations are common in alcohol withdrawal and stimulant use (e.g. cocaine, amphetamines)

Tactile

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial